A systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data

Abstract

SUMMARYSurveillance systems for varicella in Europe are highly heterogeneous or completely absent. We estimated the varicella incidence based on seroprevalence data, as these data are largely available and not biased by under-reporting or underascertainment. We conducted a systematic literature search for varicella serological data in Europe prior to introduction of universal varicella immunization. Age-specific serological data were pooled by country and serological profiles estimated using the catalytic model with piecewise constant force of infection. From the estimated profiles, we derived the annual incidence of varicella infection (/100·000) for six age groups (<5, 5–9, 10–14, 15–19, 20–39 and 40–65 years). In total, 43 studies from 16 countries were identified. By the age of 15 years, over 90% of the population has been infected by varicella in all countries except for Greece (86·6%) and Italy (85·3%). Substantial variability across countries exists in the age-specific annual incidence of varicella primary infection among the <5 years old (from 7052 to 16 122 per 100 000) and 5–9 years old (from 3292 to 11 798 per 100 000). The apparent validity and robustness of our estimates highlight the importance of serological data for the characterization of varicella epidemiology, even in the absence of sampling or assay standardization.

Burden of varicella in Central and Eastern Europe: findings from a systematic literature review

“…All CEE countries that are members of the European Union/ European Economic Area (EU/EEA) have implemented mandatory reporting of varicella [24,[33][34][35]. However, there is no standardized case definition of varicella across the EU/ EEA [36] and, consequently, obtaining reliable inter-country data on the incidence and burden of varicella is challenging [36].…”

Force of infection of Middle East respiratory syndrome in dromedary camels in Kenya

“…There are a few possible reasons why this FOI analysis identified the oldest age group as having the highest risk of infection based on model AIC. Questions remain as to whether [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28]. Furthermore, the oldest age group has a much larger age range than the others, and therefore represents a greater cumulative risk.…”

Chickenpox in Poland in 2017

“…Szczepienie przeciwko ospie wietrznej jest obecnie zalecane w 12 krajach europejskich. Bariery w powszechnym wdrażaniu tego szczepienia w Europie stanowią postrzeganie niskiego obciążenia ospą wietrzną oraz niski priorytet dla zdrowia publicznego, a także opłacalność i dostępność finansowania (3).…”